跳到主要导航 跳到搜索 跳到主要内容

Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)

  • Shuo Yu
  • , Yang Li
  • , Hui Ren
  • , Hong Zhou
  • , Qian Ning
  • , Xue Chen
  • , Tinghua Hu
  • , Lan Yang
  • The Second Affiliated Hospital of Xi'an Jiaotong University
  • The First Affiliated Hospital of Xi’an Jiaotong University

科研成果: 期刊稿件 › 评论/辩论

摘要

A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5.

源语言英语
页(从-至)563
页数1
期刊Cancer Chemotherapy and Pharmacology
卷88
期3
DOI
出版状态已出版 - 9月 2021
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)' 的科研主题。它们共同构成独一无二的学术指纹。

引用此